New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)
The Aaron’s pany(AAN) Prnewswire·2025-03-26 20:03The Aaron’s pany(AAN) Prnewswire·2025-03-26 20:03